# KPMG Private Enterprise Names Austria's AURIMOD 2026 Global Tech Innovator Winner in Lisbon

> KPMG Private Enterprise named AURIMOD the 2026 Global Tech Innovator winner for its VIVO wearable, with nearly 4,000 patients treated by year-end.

- Published: 2026-11-12T10:34:41+00:00
- Section: Business
- Author: News Desk
- URL: https://newsforagent.com/news/2026-11-12/kpmg-aurimod-global-tech-innovator-winner
- Source: [Aijourn](https://aijourn.com/last-minute-innovative-venue-switch-enables-kpmg-private-enterprise-to-crown-aurimod-the-2026-global-tech-innovator-winner/)

## Key takeaways

- AURIMOD won the 2026 KPMG Private Enterprise Global Tech Innovator competition on November 11 in Lisbon.
- AURIMOD's CE-marked VIVO wearable uses auricular vagus nerve stimulation to treat chronic pain without drugs or surgery.
- Nearly 4,000 patients will have been treated with VIVO by the end of the year, with reimbursement established in Austria.

AURIMOD won the 2026 [KPMG](https://akta.pro/company-profiles/0000eqr/kpmg) Private Enterprise Global Tech Innovator competition on November 11 in Lisbon, Portugal, for its CE-marked VIVO wearable that treats chronic pain through auricular vagus nerve stimulation. [Aijourn](https://aijourn.com/last-minute-innovative-venue-switch-enables-kpmg-private-enterprise-to-crown-aurimod-the-2026-global-tech-innovator-winner/) reported that 18 national winners pitched to five judges.

## AURIMOD's VIVO Wearable Takes the Lisbon Final

AURIMOD is a Vienna-based, commercial-stage MedTech company treating chronic pain through auricular vagus nerve stimulation. Its VIVO wearable activates the body's own pain-regulating mechanisms, offering a drug-free, non-invasive alternative to medication or surgery. By the end of the year, nearly 4,000 patients will have been treated with VIVO, and reimbursement is already established in Austria with active expansion across nine countries.

"We are honoured to be recognised on the global stage for our work in chronic pain treatment. This award reflects our team's dedication to developing a drug-free, non-invasive approach to care," said Stefan Kampusch, AURIMOD CEO and Founder. "At AURIMOD, our ambition is to make our technology available to more patients and expand access to auricular vagus nerve stimulation."

Brazil's [TissueLabs](https://akta.pro/company-profiles/000272q/tissuelabs) was first runner-up, combining 3D bioprinting, tissue-specific biomaterials and AI-powered software to engineer human tissues, with its technologies used by more than 300 institutions across over 30 countries. Sphere, an AI-native platform that automates revenue-based compliance obligations for companies trading across borders, was second runner-up. Mike Linter, KPMG Global Private Enterprise Leader, said the competition is now in its sixth year and attracted applicants from 18 countries and jurisdictions.

## KPMG's Global Network Behind the Competition

KPMG is a global Big Four network of independent member firms delivering audit, tax and advisory services across 142 countries and territories, according to akta.pro [company records](https://akta.pro/company-data). The same records list more than 275,000 partners and employees working in member firms globally. KPMG member firms operate across 142 countries and territories worldwide, and the competition has grown to include 21 countries and jurisdictions from mature and emerging markets in 2026.

## Earlier KPMG Competition Coverage

KPMG Japan announced the winners of the 2026 Global Tech Innovator Competition held in Lisbon, according to Prtimes. AURIMOD from Austria won first place, TissueLabs from Brazil took second, and Sphere from the United States took third. The inaugural KPMG Private Enterprise Global Tech Innovator Competition was introduced in 2021, when 17 countries and jurisdictions participated.

## What Comes Next for AURIMOD

AURIMOD said reimbursement is established in Austria and expansion is under way across more countries. Kampusch said the recognition encourages the team to keep working to broaden access to its technology.

## Companies in this story

- [KPMG company profile](https://akta.pro/company-profiles/0000eqr/kpmg) · website: https://kpmg.com
- [Tomorrow Street company profile](https://akta.pro/company-profiles/002mkha/tomorrow-street) · website: https://www.tomorrowstreet.co
- [TissueLabs company profile](https://akta.pro/company-profiles/000272q/tissuelabs) · website: http://www.tissuelabs.com

---
News for Agent · https://newsforagent.com/llms.txt